Cerenome (XMP1) Financial Statements
Cerenome Financial Overview
Cerenome's market cap is currently $11.54M. The company's EPS TTM is $-1033.42; its P/E ratio is -0.00; Cerenome has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.21M | $ 5.82M | $ 4.91M | $ 224.00K | $ 0.00 |
| Gross Profit | $ 4.77M | $ 4.97M | $ -4.78M | $ -488.00K | $ -66.00K |
| Operating Income | $ -15.30M | $ -14.70M | $ -13.32M | $ -19.71M | $ -12.49M |
| EBITDA | $ -18.33M | $ -8.38M | $ -12.29M | $ -18.95M | $ -12.07M |
| Net Income | $ -22.39M | $ -12.98M | $ -13.32M | $ -20.27M | $ -13.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.76M | $ 3.61M | $ 8.55M | $ 18.12M | $ 18.40M |
| Total Assets | $ 16.32M | $ 6.63M | $ 11.39M | $ 23.87M | $ 21.98M |
| Total Debt | $ 821.00K | $ 3.37M | $ 4.18M | $ 5.75M | $ 6.99M |
| Net Debt | $ -7.94M | $ 3.29M | $ -4.37M | $ -12.37M | $ -11.41M |
| Total Liabilities | $ 12.33M | $ 15.58M | $ 12.74M | $ 17.42M | $ 11.14M |
| Stockholders' Equity | $ 4.00M | $ -8.95M | $ -1.35M | $ 6.45M | $ 10.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.84M | $ -10.70M | $ -13.01M | $ -13.73M | $ -10.42M |
| Operating Cash Flow | $ -20.77M | $ -10.55M | $ -12.85M | $ -12.97M | $ -10.28M |
| Investing Cash Flow | $ -854.00K | $ -4.11M | $ -160.00K | $ -759.00K | $ -82.00K |
| Financing Cash Flow | $ 30.31M | $ 6.19M | $ 3.44M | $ 13.45M | $ 20.42M |
Currency in USD
